Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Project Name | Project Stage | Molecule Type | Host Species | Therapeutic Area | Indications |
EpCAM CAR-T -01 | IIT | Solid Tumor | Gastric Cancer |
Expression analysis of human EpCAM on HEK293/Human EpCAM Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human EpCAM Stable Cell Line or negative control cell using PE-labeled anti-human EpCAM antibody.
Immobilized Human EpCAM, Llama IgG2b Fc Tag (Cat. No. EPM-H5259) at 1 μg/mL (100 μL/well) can bind Anti-EpCAM Antibody, Human IgG1 with a linear range of 0.2-8 ng/mL (QC tested).
The purity of Biotinylated Rhesus macaque EpCAM / TROP1 Protein, His,Avitag (Cat. No. EPM-R82E3) is more than 90% and the molecular weight of this protein is around 28-40 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Anti-EPCAM CAR-T cell therapy (Sinobioway) | Phase 2 Clinical | Beijing Sinobioway Bioengineering Group Co Ltd | Liver Neoplasms; Stomach Neoplasms | Details | |
A-337 | A-337 | Phase 1 Clinical | Evive Biotech Ltd | Neoplasms | Details |
Tefibazumab | INH-H2002 | Bristol-Myers Squibb Company | Details | ||
IMC-001 (Immunofoco) | Phase 1 Clinical | Suzhou Immunofoco Biotechnology Co Ltd | Stomach Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Hepatocellular | Details | |
M-701 | M-701 | Phase 2 Clinical | Wuhan Yzy Biopharma Co Ltd, Cspc-Nbp Pharmaceutical Co Ltd | Hydrothorax; Neoplasms; Ascites; Pleural Effusion, Malignant; Carcinoma, Non-Small-Cell Lung | Details |
Catumaxomab | LP000 | Phase 3 Clinical | Trion Research, Neovii Biotech Gmbh | Ovarian Neoplasms; Stomach Neoplasms; Carcinoma; Neoplasms; Carcinoma, Ovarian Epithelial; Colonic Neoplasms; Ascites; Urinary Bladder Neoplasms; Breast Neoplasms | Details |
Oportuzumab monatox | 4D5MOCB-ETA; VB4-845; VB-4847; B-4845; VB-845 | Phase 3 Clinical | Viventia Biotech Inc, Sesen Bio Inc | Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasms, Squamous Cell; Urinary Bladder Neoplasms; Carcinoma, Squamous Cell; Mouth Neoplasms | Details |
This web search service is supported by Google Inc.